OxySure (OXYS) Doubles Production Capacity in Response to Booming Backlog
Frisco, Texas, February 10, 2016 – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative emergency medical solutions today announced that the Company has doubled its production capacity in response to a rapidly increasing backlog. Said Richard Bryant, OxySure’s Production Manager: “Through recent investments in infrastructure and additional manufacturing staff we were able to reduce our current backlog from two